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Introduction
The global epidemiology of methicillin-resistant Staphy-
lococcus aureus (MRSA) is heterogeneous.
Objectives
The objective of this study was to evaluate the epide-
miology of MRSA in Switzerland over a 10-year period.
Methods
We conducted a descriptive analysis of individual patient-
level and aggregate MRSA data from the ANRESIS from
2004 to 2013.We also performed a time series analysis to
characterize trends of MRSA and non-multidrug-resistant
MRSA (Nm-MRSA, as a potential marker for community-
associated MRSA, which was defined as being susceptible
to at least three of the following agents: ciprofloxacin, clin-
damycin, tetracycline and trimethoprim-sulfamethoxazole
(TMP/SMX) with stratification by Swiss regions,age-group
and patient location.
Results
Overall, 13,675 MRSA isolates were included. Although
the proportion of MRSA among S. aureus (from 14% in
2004 to 10% in 2013 and the MRSA incidence decreased
over time from 0.98 in 2004 to 0.58 per 1,000 discharged
patients in 2013), an increasing trend of NmMRSA
(+0.84% per quarter) was observed. Variation in the geo-
graphical distribution was noted, with a decrease in the
proportion of MRSA among S. aureus in the Western
region and Ticino (from 25% in 2004 to 16% in 2013 and
from 20% to 15%) and stable and low prevalences (3-5%)
in the Eastern and Central regions. We observed an
increase in MRSA among S. aureus in outpatients
(+0.044% per quarter) and a decrease in inpatients
(-0.13% per quarter). Further analysis showed an increase
in MRSA rates among S. aureus in younger age groups
(2-15y,+0.11%per quarter) compared to decreasing
MRSA rates in S. aureus for older age(>65 years –0.29%
per quarter). Resistance to ciprofloxacin,clindamycin,gen-
tamicin and erythromycin in MRSA strains decreased.
Conversely, resistance to tetracycline, TMP/SMX, fusidic
acid and rifampicin remained almost stationary and low
over the study period.
Conclusion
The proportion of MRSA among S. aureus in Switzerland
decreased overall. The Ticino and West regions have
moved from having a hyper-endemic MRSA prevalence
comparable with neighboring countries,to lower levels of
prevalence. MRSA appears to be an increasing problem in
the younger population and in outpatients. The increased
susceptibility to several antibiotic classes other than b-
lactams suggests dissemination of strains, which have clas-
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